06 December 2008
Onders, RP, et alia
Complete worldwide operative experience in laparoscopic diaphragm pacing: results and differences in spinal cord injured patients and amyotrophic lateral sclerosis patients
Complete worldwide operative experience in laparoscopic diaphragm pacing: results and differences in spinal cord injured patients and amyotrophic lateral sclerosis patients - PubMed

March, 2009 {$31.50?}
Onders, RP, et alia
Amyotrophic lateral sclerosis: the Midwestern surgical experience with the diaphragm pacing stimulation system shows that general anesthesia can be safely performed
Amyotrophic lateral sclerosis: the Midwestern surgical experience with the diaphragm pacing stimulation system shows that general anesthesia can be safely performed - PubMed

24 October 2011
Gonzalez-Bermejo, J, et alia
Diaphragm pacing improves sleep in patients with amyotrophic lateral sclerosis - PubMed

28 September 2011
Humanitarian Device Exemption (HDE) H100006
United States Food and Drug Administration
Humanitarian Device Exemption (HDE)
remains active to this day . . .

The study reports, above, show implied efficacy due improved patient survival medians . . . the following reports shows electromyogram intel reflecting synaptic reactivation subsequent to stimulation:

March 2015 {$31.50?}
Onders, RP, et alia
Identification of unexpected respiratory abnormalities in patients with amyotrophic lateral sclerosis through electromyographic analysis using intramuscular electrodes implanted for therapeutic diaphragmatic pacing
Identification of unexpected respiratory abnormalities in patients with amyotrophic lateral sclerosis through electromyographic analysis using intramuscular electrodes implanted for therapeutic diaphragmatic pacing - PubMed

. . . which leads us to 'lunatic ridge . . .' in the frontier of Amyotrophic Lateral Sclerosis.

And the table again:
https://tinyurl.com/ResapiD

shows slowing of deaths for surgical cohorts but increasing deaths for NiV cohort . . . in other words, after the bad start, even these studies developed affirming evidence of benefit . . . contravening the seeming adverse studies . . . leading to the question of what happened? The hospice issue shows many ineligible candidates were admitted to the study . . . but not why the same happened. Such is what I am working on in the present moment . . . .

The rare new case disclosures suggest patients are needlessly dying and scientific research is slowing . . . I am trying to correct the problems.